No takes yet. Share an insight, caveat, or question.
P2RX7 promotes T cell exhaustion and responsiveness to immunotherapy in chronic viral infection, indicating its potential as a therapeutic target.
Salgado et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: